POPULARITY
Categories
Episode 170. I'll share my top recommended resources for the USMLE Step 1, including specifics about the best question banks for Step 1. Plus, I'm giving away a brand-new copy of Crush Step 1! There are three ways to enter this special giveaway: 1. Rate on Spotify OR rate and review on Apple (5-stars please!) Screenshot and email me (firstlinepodcast@yahoo.com) or post on Instagram and tag me @fristlinepodcast2. Post the episode in your Instagram story (and tag me) with a key takeaway from the episode3. Sign up for the Medical Student CV Masterclass hereThe winner will be announced on May 12th, so you have until then to enter up to 3 times!Visit First Line's website and blog: https://www.firstlinepodcast.comEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
Featuring an interview with Dr Adam M Brufsky, including the following topics: Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00) Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52) Clinical Investigator Survey Results (10:05) CME information and select publications
Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions. CME information and select publications here.
Featuring a slide presentation and related discussion from Dr Adam M Brufsky, including the following topics: Mechanism of action of and long-term data with CDK4/6 inhibitors in the management of metastatic breast cancer (mBC) (0:00) Comparing safety profiles of CDK4/6 inhibitors (9:49) Role of CDK4/6 inhibitors in therapy for older patients with mBC (24:06) Real-world evidence with CDK4/6 inhibitors (27:31) CME information and select publications
Interview with Benjamin N. Rome, MD, MPH, author of Use and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US: Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US. Hosted byAdewole S. Adamson, MD. Related Content: Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US
JAMA Dermatology Author Interviews: Covering research on the skin, its diseases, and their treatment
Interview with Benjamin N. Rome, MD, MPH, author of Use and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US: Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US. Hosted byAdewole S. Adamson, MD. Related Content: Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US
CME credits: 0.25 Valid until: 16-04-2026 Claim your CME credit at https://reachmd.com/programs/cme/first-line-chemotherapy-options-in-metastatic-pdac/33135/ Pancreatic ductal adenocarcinoma, also known as PDAC, is a lethal disease that is usually diagnosed at an advanced stage with an extremely poor prognosis. Advancements in treatment regimens have improved survival rates, but early diagnosis is crucial for improving outcomes, and awareness of risk factors is vital for early diagnosis. Cytotoxic chemotherapy is the cornerstone of treatment for advanced or metastatic cases, although molecularly targeted therapies and immunotherapies may benefit select patients. Treatment selection depends on several factors, including patients' performance status and comorbidities, which should be considered alongside the efficacy and safety profiles of the different chemotherapy regimens. This two-part programme provides an overview of the different first- and second-line chemotherapy options. Complete both modules, answer pre- and post-test questions and start earning CME credits. This programme is also featured on the COR2ED website, here: Chemotherapy Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
Episode 169. Is coffee good for you? Can it fit into a healthy diet? Let's dive into the health benefits and potential risks of coffee, including its role in disease prevention and how many cups I've decided to have daily.Visit First Line's website and blog: https://www.firstlinepodcast.comEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
READY RADIO: First Line of Defense Against Unconstitutional Overreach 4.11.25 by John Rush
Featuring an interview with Dr Justin F Gainor, including the following topics: Duration of responses observed with ALK inhibitors in patients with ALK-positive metastatic non-small cell lung cancer (mNSCLC) (0:00) Current role of other systemic therapy options for the treatment of ALK-positive mNSCLC; management of oligometastatic disease (8:38) Local therapy approaches for treating CNS disease in ALK-positive mNSCLC (18:32) Tolerability profile of lorlatinib (23:28) Review of clinical investigator survey results (37:08) Novel ALK inhibitors under clinical development (53:22) CME information and select publications
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. CME information and select publications here.
Featuring a slide presentation and related discussion from Dr Justin F Gainor, including the following topics: Duration of responses observed with ALK inhibitors in patients with ALK-positive metastatic non-small cell lung cancer (mNSCLC) (0:00) Current role of other systemic therapy options for the treatment of ALK-positive mNSCLC; management of oligometastatic disease (8:38) Local therapy approaches for treating CNS disease in ALK-positive mNSCLC (18:32) Tolerability profile of lorlatinib (23:28) Review of clinical investigator survey results (37:08) Novel ALK inhibitors under clinical development (53:31) CME information and select publications
Episode 168. We explore how each Enneagram type can reflect traits of specific personality disorders in an unhealthy state and how knowing this can encourage self-awareness and personal growth.Visit First Line's website and blog: https://www.firstlinepodcast.comEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
In today's episode, supported by EMD Serono, we had the pleasure of speaking with Chandler Park, MD, about the first-line treatment of patients with bladder cancer. Dr Park is a medical oncologist at the Norton Cancer Institute in Louisville, Kentucky. In our exclusive interview, Dr Park discussed the core regimens in the current frontline bladder cancer treatment paradigm, ways that this paradigm is expected to evolve in the coming months and years, and how the choice of frontline therapy influences treatment decision-making regarding subsequent lines of therapy.
Parenting teens today can feel like trying to hold back a tidal wave. We want to protect them, guide them, and set them up for success—but how do we do that without burning out or pushing them away? In this episode, we're tackling three crucial parenting strategies: Setting Boundaries with Technology—How to create limits that actually stick, without constant battles. Why Kids Don't Always Need Therapy, Parents Need to Learn Tools—Understanding when their struggles are really a reflection of their environment. Raising Independent Teens—How to help them take responsibility for their own lives instead of constantly relying on you to manage everything. If parenting feels like an uphill battle, there's a better way. Let's make it easier. Book a free Peaceful Parenting Call, and in 45 minutes, we'll create a plan that actually works for your family. About my guest: Nicole Runyon, LMSW, is an esteemed psychotherapist specializing in parenting, author, and keynote speaker renowned for her expertise in child and adolescent mental health, backed by an extensive 21-year career in the field. Nicole is also the mother of 2 children. You can find her book, Free to Fly right HERE Instagram and FB- @igenerationmentalhealth LinkedIn- Nicole Runyon
Episode 167. Learn how to create a standout CV as a medical student with expert insights from someone who has successfully navigated the process and helped hundreds others do the same. Listen in to hear how to access my CV template crafted just for medical students.Visit https://www.firstlinepodcast.com/ to access the course tab for my NEW Medical Student CV Masterclass and the services tab to learn more about my one-on-one individualized editing services.For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
Join Professors Iain McInnes and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers: effectiveness of JAKi compared with bDMARDs on pain reduction and effective second‑line b/tsDMARD for patients with rheumatoid arthritis unresponsive to first‑line b/tsDMARDs.
A phase 3 study showed that combining pelabresib with ruxolitinib significantly improved spleen volume reduction and symptom relief in myelofibrosis patients compared to ruxolitinib alone, offering a promising new treatment option. Long-term use of gantenerumab may delay Alzheimer's dementia onset in individuals with inherited Alzheimer's, supporting the amyloid hypothesis and paving the way for future prevention strategies. Phase 3 trials demonstrated that povorcitinib, an oral JAK1 inhibitor, significantly improved clinical outcomes in adults with moderate to severe hidradenitis suppurativa, potentially offering a new treatment option. Research linked red meat allergy to bites from additional tick species, expanding the geographic risk area and highlighting the need for clinicians to consider this diagnosis in patients with unexplained allergic symptoms following tick bites.
In this episode, listen to Stephanie L. Graff, MD, FACP, FASCO; and Laura M. Spring, MD, share their clinical insights and takeaways regarding the current treatment landscape for first-line treatment of patients with HER2-positive metastatic breast cancer including:Data from multicenter, single-arm, phase IIIb/IV DESTINY-Breast12 evaluating trastuzumab deruxtecan (T-DXd) in patients with advanced HER2-positive metastatic breast cancer and 2 or fewer previous therapiesTreatment sequencing and preferred treatment options in patients with brain metastasesResults from phase III PATINA trial of trastuzumab, pertuzumab, plus endocrine therapy with or without palbociclib in hormone-receptor positive/HER2-positive metastatic breast cancerThoughts on the use of T-DXd earlier in the treatment paradigm in light of recent results from the PATINA trial and highly anticipated results from the DESTINY-Breast09 trialProgram faculty:Stephanie L. Graff, MD, FACP, FASCODirector of Breast Oncology, Brown University HealthCo-Lead, Breast Cancer Translational Disease Research GroupLegorreta Cancer Center at Brown UniversityAssociate Professor of MedicineWarren Alpert Medical School of Brown UniversityProvidence, Rhode IslandLaura M. Spring, MDBreast Medical OncologistMass General Hospital Cancer CenterHarvard Medical SchoolBoston, Massachusetts Resources:To access the patient cases associated with this podcast discussion, please visit the program page and register for an upcoming webinar on this topic.
To close out this series on prayer, we delve into the raw honesty of Jeremiah's lament in Lamentations 3 and Jesus' anguish in Gethsemane. These biblical accounts reveal that it's okay to struggle with God's will and express our pain to Him. We learn that being godly doesn't mean always feeling okay or having a positive attitude. Instead, true faith allows us to bring our burdens, confusion, and even anger to God. The message emphasizes the difference between isolation and solitude in our spiritual journey. While isolation can be dangerous, solitude with God can be transformative. This teaching encourages us to run to the Father with our problems rather than away from them. Ultimately, we're reminded that God's love is steadfast, His mercies are new every morning, and His faithfulness endures even in our darkest valleys. This message challenges us to be honest in our prayers and to cling to hope, even when we can't feel or see God's presence.
“Primary care physicians are your first line of defense against cancer,” said Matthew Farrell, M.D., an Ohio State Wexner Medical Center primary care physician and a clinical associate professor of family and community medicine. Prevention, screenings and early detection are crucial and begins with a patient's family history with cancer and other medical issues. “We are thorough and ask about their first-degree relatives, their parents, siblings and children, and their secondary relatives, such as grandparents and aunts and uncles,” Farrell said. “If I see a pattern, a certain number of relatives with the same cancer, especially at an early age, there could be a genetic factor.” A patient with an inherited genetic mutation will then be screened at an earlier age and more often. Dr. Farrell also talked about the importance of children receiving the Human Papillomavirus (HPV) vaccine that prevents certain types of cancer. He examines patients to detect skin cancer and melanoma in the early stages. “Skin cancer is the most common form of cancer and it's personal for me; my mother was diagnosed with melanoma three times … and she's doing fine.” Breast cancer and prostate cancer are two of the most common forms of cancer. Dr. Farrell discussed when women should begin getting yearly mammograms, and why and when men should begin to undergo regular Prostate-Specific Antigen (PSA) tests. Men and women without a family history of colorectal cancer should get their first colonoscopy at 45. “My brother-in-law was 52 when he had his first colonoscopy,” Dr. Farrell said. “They found a large tumor in his colon; it was removed, and he's been cancer free for 20 years now.” Lung cancer screenings are relatively new and recommended for long-time smokers. They are vital because “if you wait until there are symptoms it's very hard to treat and cure,” Dr. Farrell said, adding “I'm fortunate to be part of the Ohio State system and the James where we have experts and specialists for every type of cancer and medical issue my patients have.”
Episode 166. We'll cover how Enneagram stances shape the way you interact with others and navigate life. This episode breaks down the aggressive, withdrawing, and dependent stances, offering insight into their challenges, strengths, and paths for personal growth.- Enneagram stances- Orientation to time- Repressed centers of intelligenceVisit First Line's website and blog: https://www.firstlinepodcast.comEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
Landtrust Title Services and attorneys Mark Herrick and Nick Jaworski break down how to secure funds for a real estate transaction. Wire fraud, Seller Impersonation and how to insure your funds for 2.5 million dollars are covered.https://www.ah-lawyers.com/https://www.vjplawyers.com/nicholas-p-jaworskiIntroduction to the Episode (00:00:00)Speaker Introductions (00:01:32)Cybercrime Statistics (00:02:50)Creating a Value Proposition (00:03:49)Market Trends in Real Estate Fraud (00:05:37)Importance of Email Security (00:06:25)Real Estate Fraud Overview (00:08:29)Red Flags of Seller Impersonation (00:09:20)Urgency in Transactions (00:10:54)Seller Communication Patterns (00:12:00)Identifying Fraudulent Sellers (00:12:21)Power of Attorney in Transactions (00:14:20)Notary Verification Process (00:15:34)Remote Online Notary (00:18:27)Realtor's Human Contact (00:18:33)Realtor-Attorney Partnership (00:19:08)Seller Impersonation Fraud (00:19:31)Verifying Identity (00:20:45)Red Flags of Fraud (00:21:04)First Line of Defense (00:22:18)Minimizing Fraud Steps (00:23:12)Client Education on Fraud (00:23:33)Email Communication Vigilance (00:24:30)Personal Experience with Fraud (00:25:25)Immediate Action on Wire Fraud (00:27:20)Legal Steps for Defrauded Sellers (00:27:52)Potential Liability (00:29:01)Tracking Fraud Attempts (00:30:49)Recent Fraud Case Example (00:32:01)Bank Alertness to Fraud (00:34:26)Soft Spots in Transactions (00:35:02)Clean Title Importance (00:36:08)Red Flags in Real Estate Transactions (00:36:34)Verifying Seller Identity (00:37:39)Estate Sales Challenges (00:38:04)Seller Verification Steps (00:39:17)Escrow Security Team (00:40:29)Payoff Verification Process (00:41:25)Handling Fraudulent Payoffs (00:43:27)Wire Fraud Precautions (00:46:00)Closing Lock Security Features (00:48:25)Transaction Completion and Team Introduction (00:51:28)AI and Fraud (00:52:39)Understanding Foreign Investor Transactions (00:55:01)Title Companies and Holdbacks (00:55:47)Importance of Verification (00:56:09)Role of Title Companies (00:56:49)Closing Remarks and Thanks (00:57:31)Podcast Conclusion (00:58:12)People, Not Titles podcast is hosted by Steve Kaempf and is dedicated to lifting up professionals in the real estate and business community. Our inspiration is to highlight success principles of our colleagues.Our Success Series covers principles of success to help your thrive!IG - https://www.instagram.com/peoplenotti...FB - https://www.facebook.com/peoplenottitlesTwitter - https://twitter.com/sjkaempfSpotify - https://open.spotify.com/show/1uu5kTv...
On this episode of The Sick Podcast, Pierre McGuire joins Tony Marinaro to discuss the Montreal Canadiens win over the Vancouver Canucks and much more. Later in the show, Tony and Pierre take questions from fans. Learn more about your ad choices. Visit megaphone.fm/adchoices
Cybersecurity and the role of internal audit, an urgent call to action: The forces driving business growth and efficiency contribute to a broad attack surface for cyber assaults. How is the end user protected with good service while not being compromised? First Line includes internet, cloud, mobile, and social technologies, now mainstream, are platforms inherently oriented for sharing. Outsourcing, contracting, and remote workforces are shifting operational control. Second line includes information and technology risk management leaders who establish governance and oversight, monitor security operations, and take-action as needed, often under the direction of the chief information security officer (CISO) Third line of cyber defense—independent review of security measures and performance by the internal audit function. Internal audit should play an integral role in assessing and identifying opportunities to strengthen enterprise security. At the same time, internal audit has a duty to inform the audit committee and board of directors that the controls for which they are responsible are in place and functioning correctly, a growing concern across boardrooms as directors face potential legal and financial liabilities.
Episode 165. Let's break down the Supplemental Offer and Acceptance Program, also known as SOAP, and how to know your chance of needing to SOAP. We'll also cover the four steps all applicants should do ahead of Match Week to prepare for the scenario of not matching on Monday.Visit First Line's website and blog: https://www.firstlinepodcast.comEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Yi Bin Chen, MD Guest: Olaf Penack, MD For the past several decades, standard treatment for acute graft-versus-host disease (aGVHD) has been systemic high-dose steroids.1 While essential in some ways to initially control aGVHD, steroids are not beneficial in the long run due to the immunosuppression and toxicities associated with high cumulative doses.1,2 So what can be done moving forward to improve first-line steroid response and minimize cumulative steroid exposure? Joining Dr Charles Turck to discuss the potential of nonimmunosuppressive steroid-sparing agents for the first-line treatment of aGVHD are Drs Yi Bin Chen and Olaf Penack. Dr Chen is the Director of the Hematopoietic Cell Transplant and Cell Therapy Program at Massachusetts General Hospital, and Dr Penack is a senior physician and principal investigator within Hematology and Oncology at Charité Berlin. References: Bell EJ, Yu J, Bhatt V, et al. Healthcare resource utilization and costs of steroid-associated complications in patients with graft-versus-host disease. Transplant and Cell Ther. 2022;28(10):707.e1-707.e7. Martin PJ, Rizzo JD, Wingard JR, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012;18(8):1150-1163. © 2025 CSL BehringCMD-964-0016-JAN25
Episode 164. I share my personal journey of choosing not to sleep train my baby while challenging the common belief that it is a necessity for parents. Hear my reflections on my experience over the past 18 months while we discuss attachment, intuition, and the nuances of infant sleep. Visit First Line's website and blog: https://www.firstlinepodcast.comEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
In this First Line episode of the Pro Hockey News Podcast, Adam, Lonny and Richard talk about the buyers and sellers a week out of the NHL Trade Deadline and critique the 4 Nations Quarter Century Teams. The episode is capped off with the #PHNPicks of the week. Follow us on on Bluesky @PHNPodcast.Thanks to our sponsors:My Custom Sports Chair Enter code PHN15 for 15% off your purchaseManscaped save 20% on your purchase going to manscaped.com/prohockeynewsLDE Affinity JewelryFoCo
We often focus on addressing problems after they've occurred in the nonprofit and social sector, but what if we could intervene earlier?After 30 years of research in prevention science, the evidence is clear: many behavioral health issues and related challenges can be prevented.I'm joined by Mitchell Moore, an advanced certified prevention specialist, to discuss the power of early intervention in preventing behavioral health problems—specifically in the context of youth and families.(01:02) Why Mitchell believes funding should shift from reactive solutions like treatment and incarceration to proactive prevention.Skip Ahead:(04:44) The role of data in helping Prevention Training Services reach out and train so many people.(07:57) What a 9-month community assessment revealed and how it shifted their prevention strategy.(16:45) How media literacy, a key aspect of prevention work, has made him hyper-aware of product placement in movies and commercials.Connect with Mitchell Moore and learn more about Prevention Training Services.Read the full show notes HERE.
Episode 163. Learn how to craft a standout CV at every stage of your medical journey with this practical checklist for pre-meds, medical students, and residents. Let's quickly run through formatting tips and section-by-section guidance to ensure your CV is polished, professional, and application-ready in under 15 minutes.For more tips on medical CVs, check out episode 81.Visit First Line's website and blog:https://www.firstlinepodcast.comEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription usehttps://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
Episode 162. Let's break down the prevalent misconceptions and concerns surrounding SSRIs, a common treatment for depression, anxiety, PTSD, and other mental health conditions. We'll explore short-term and long-term side effects, the importance of individualized treatment, and how to navigate medication decisions with the guidance of a healthcare provider.*Trigger warning: Please note this episode briefly mentions suicidal ideation and suicidal behavior.*Visit First Line's website and blog:https://www.firstlinepodcast.comFor a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstlineContent on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
Meet Rickard Rakell, first-line former snub! Hear award-winning columnist Dejan Kovacevic's Daily Shots of Steelers, Penguins and Pirates -- three separate podcasts -- every weekday morning on the DK Pittsburgh Sports podcasting network, available on all platforms: https://linktr.ee/dkpghsports Learn more about your ad choices. Visit megaphone.fm/adchoices
Hear award-winning columnist Dejan Kovacevic's Daily Shots of Steelers, Penguins and Pirates -- three separate podcasts -- every weekday morning on the DK Pittsburgh Sports podcasting network, available on all platforms: https://linktr.ee/dkpghsports
Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York discusses available data guiding treatment decision-making for patients with newly diagnosed multiple myeloma. CME information and select publications here.
Featuring an interview with Dr Saad Zafar Usmani, including the following topics: Optimizing treatment intervention for patients with newly diagnosed multiple myeloma (MM) (0:00) Role of anti-CD38 antibodies in induction and maintenance therapy for patients with newly diagnosed disease (4:22) Case: A woman in her late 70s with revised International Staging System (R-ISS) Stage II IgG kappa myeloma who received D-Rd followed by maintenance daratumumab (14:02) Case: A man in his early 60s with double-hit myeloma who received D-KRd and carfilzomib maintenance therapy (26:10) Case: A man in his early 70s with R-ISS Stage III IgG kappa myeloma and translocation (4;14) who deferred transplant (33:24) Future directions in the management of MM (40:37) CME information and select publications
Summary: In this conversation, Dave Quick shares his experiences as a firefighter and company officer, reflecting on a close call during a fire incident and the lessons learned from it. He discusses the importance of mentorship, the challenges of transitioning to an officer role, and the critical responsibilities of the second due engine. Quick emphasizes the need for effective training and preparation, particularly in handling emergencies like burst lines. He also highlights the significance of learning from mistakes and fostering a culture of growth within the fire service. The discussion culminates in an overview of Quick's Engine Boss presentation, aimed at equipping aspiring officers with the necessary skills and mindset for effective leadership in firefighting. Takeaways: The importance of doing a 360 at a fire scene. Mentorship can significantly impact a firefighter's development. Promoting to officer requires a different skill set than being a firefighter. The second due engine plays a crucial role in fire response. Effective communication is vital during emergencies. Training and preparation are key to successful firefighting. Learning from mistakes is essential for growth in the fire service. Company officers need to be prepared for unexpected situations. A culture of accountability and support enhances team performance. Continuous learning and reflection are necessary for effective leadership. Navigating Fire Incidents: Lessons from the Front Lines From Firefighter to Officer: A Journey of Growth "We got real lucky there." "I realized that I didn't have the skills necessary." "I want to continue to feed that hunger." Chapters: 00:00 The Fire Incident: A Close Call 02:35 Reflections on Leadership and Mentorship 05:15 Preparing for Promotion: The Journey of a Firefighter 07:59 The Role of the Company Officer 10:56 Operational Strategies: Laying Out and Water Supply 13:38 Decision Making on the Fire Ground 16:41 The Importance of Communication and Radio Discipline 19:12 Training and Development: The Engine Boss Presentation 32:00 Navigating Rookie Responsibilities 33:03 Real-Life Fire Incident Analysis 38:56 Lessons Learned from Fireground Challenges 40:09 The Importance of Preparation and Experience 42:44 Debriefing and Learning from Experiences 45:53 Connecting with Rookies and Building Relationships 46:47 The Passion for Firefighting and Mentorship 50:44 The Joy of Success in Firefighting 55:50 Preparing Future Leaders in Fire Service
Featuring a slide presentation and related discussion from Dr Saad Zafar Usmani, including the following topics: Evolution of therapeutic decision-making for patients with newly diagnosed multiple myeloma (MM) (0:00) Quadruplet therapy for transplant-eligible patients with newly diagnosed MM (6:26) Daratumumab with lenalidomide as maintenance therapy after transplant in newly diagnosed MM (16:16) Therapeutic options for transplant-ineligible patients with MM (19:51) CME information and select publications
Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York discusses available data guiding treatment decision-making for patients with newly diagnosed multiple myeloma. CME information and select publications here.
Episode 161. Let's explore the power of positive affirmations from a Christian perspective, focusing on verses from the Book of Psalms to intentionally support spiritual and mental health. I share how incorporating these 5 Bible-based affirmations into daily routines can strengthen faith and set a positive mindset for the day ahead. Thank you Befree for sponsoring this episode. Visit befreeco.com to learn more! Visit First Line's website and blog: https://www.firstlinepodcast.com Editing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstline Content on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
In this week's episode we'll learn more about a phase 2 trial of first-line zanubrutinib, obinutuzumab, and venetoclax in TP53-mutated mantle cell lymphoma; early development of hyperdiploidy in multiple myeloma; and a phase 1 trial of the asparaginase pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia.Featured Articles:Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutationDevelopment of hyperdiploidy starts at an early age and takes a decade to completeA phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia
The defense of Greenland is in the hands of a handful of men - Denmark's Sirius Patrol. They're an elite long range reconnaissance patrol unit that prowls Greenland's coastline on dogsleds looking for things that shouldn't be there. These guys are one of the most elite and interesting units in NATO's arsenal
Episode 160. Let's dive into the powerful connection between nutrition and mental health, exploring how a diet rich in brain-boosting superfoods can improve mental wellness and even reduce anxiety and depression. We'll discuss the Mediterranean diet, key nutrients like omega-3s and magnesium, and practical tips for incorporating these foods into your daily routine for optimal brain health. As promised, here are the products I mentioned in this episode: Organic Whole Milk with DHA Omega-3: https://amzn.to/4gfmaIw Garden of Life Organic Flax and Chia Seeds: https://amzn.to/4hzbLJ7 Chopped Walnuts from Whole Foods: https://amzn.to/3CrP0rw Organic Raw Almonds: https://amzn.to/3WAojb7 Organic Raw Cashews: https://amzn.to/4hcwZws Organic Pumpkin Seeds: https://amzn.to/4haoimm Organic Spinach from Whole Foods: https://amzn.to/4hbZ9aR Organic Avocados from Whole Foods: https://amzn.to/4ggh8Mf My Favorite Dark Chocolate: https://amzn.to/3PT5P1u Organic Whole Milk Probiotic Yogurt: https://amzn.to/3Cq33Ob Organic Rolled Oats: https://amzn.to/40QwHWt Organic Blueberries: https://amzn.to/4aAyYYV Visit First Line's website and blog: https://www.firstlinepodcast.com Thank you to befree for partnering with First Line. Visit befreeco.com for more info. Content on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
Episode 159. Let's wrap-up the baby-led weaning series by reviewing the 12 new foods I introduced to my 11-month-old and how I reintroduced the foods in subsequent months. Here are the product recommendations as promised: Quick-Frozen Cherries: https://amzn.to/4h1NECQ Organic Red Lentils: https://amzn.to/3DXBHQ7 Unsweetened Acai: https://amzn.to/3PG9u2J Organic Zucchini Spirals: https://amzn.to/4g9SaxH Organic Frozen Jackfruit: https://amzn.to/3E0O5yB Organic Shredded Romaine: https://amzn.to/3C4gXWh Trader Joe's Tricolor Quinoa: https://amzn.to/42e3Jkm Unsalted Black Beans: https://amzn.to/3WoX576 Whole Foods Italian Barley: https://amzn.to/40DNxaL Provencal Vegetable Blend: https://amzn.to/4aqmzGP (Note that this one is higher in sodium. I didn't use this until my child was older, and I drain the sauce) No Salt Added Black Eyed Peas: https://amzn.to/4gYq0Hv Thank you to befree for sponsoring this episode. Visit befreeco.com Visit First Line's website and blog: https://www.firstlinepodcast.com Editing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.fiverr.com/firstlinepod For a discount on your TrueLearn subscription use https://truelearn.referralrock.com/l/firstline/ and code firstline Content on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.
In this Oncology Unplugged discussion, Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, and Joshua Brody, MD, director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai in New York, New York, explored the heterogeneity of lymphoma subtypes and the evolution of treatment paradigms across B-cell malignancies. They discussed the treatment challenges posed by the diverse spectrum of lymphomas, ranging from indolent subtypes, such as follicular lymphoma, to aggressive diseases like Burkitt lymphoma.
#OKINAWA: Observations re the Okinawa chain of islands, also known as the Ryuku chain, the serves as the first line of defense against a PLA attack on Taiwan. Grant Newsham, author, "When China Attacks." https://japan-forward.com/okinawa-its-still-important-and-often-misunderstood/1945 Okinawa Bailey Bridge constructed after the concrete bridge was destroyed in the Battle of Okinawa.